- Home
- BFRGW vs UCTT Comparison
BFRGW vs UCTT Comparison
Compare BFRGW & UCTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFRGW
- UCTT
- Stock Information
- Founded
- BFRGW 2017
- UCTT 1991
- Country
- BFRGW United States
- UCTT United States
- Employees
- BFRGW 11
- UCTT N/A
- Industry
- BFRGW Retail: Computer Software & Peripheral Equipment
- UCTT Semiconductors
- Sector
- BFRGW Technology
- UCTT Technology
- Exchange
- BFRGW Nasdaq
- UCTT Nasdaq
- Market Cap
- BFRGW N/A
- UCTT N/A
- IPO Year
- BFRGW N/A
- UCTT 2004
- Fundamental
- Price
- BFRGW $0.70
- UCTT $24.43
- Analyst Decision
- BFRGW
- UCTT Strong Buy
- Analyst Count
- BFRGW 0
- UCTT 4
- Target Price
- BFRGW N/A
- UCTT $56.75
- AVG Volume (30 Days)
- BFRGW 37.4K
- UCTT 716.3K
- Earning Date
- BFRGW 03-28-2025
- UCTT 05-05-2025
- Dividend Yield
- BFRGW N/A
- UCTT N/A
- EPS Growth
- BFRGW N/A
- UCTT N/A
- EPS
- BFRGW N/A
- UCTT 0.52
- Revenue
- BFRGW N/A
- UCTT $2,097,600,000.00
- Revenue This Year
- BFRGW N/A
- UCTT $7.22
- Revenue Next Year
- BFRGW N/A
- UCTT $10.09
- P/E Ratio
- BFRGW N/A
- UCTT $46.98
- Revenue Growth
- BFRGW 550.00
- UCTT 20.93
- 52 Week Low
- BFRGW $1.01
- UCTT $22.40
- 52 Week High
- BFRGW $1.25
- UCTT $56.47
- Technical
- Relative Strength Index (RSI)
- BFRGW N/A
- UCTT 35.18
- Support Level
- BFRGW N/A
- UCTT $22.40
- Resistance Level
- BFRGW N/A
- UCTT $25.47
- Average True Range (ATR)
- BFRGW 0.00
- UCTT 1.68
- MACD
- BFRGW 0.00
- UCTT -0.38
- Stochastic Oscillator
- BFRGW 0.00
- UCTT 13.93
About BFRGW Bullfrog AI Holdings Inc.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.